ArticleFrontiers in pediatrics2026
Terminal 4q duplication and extended 10q deletion in a preterm infant with linear growth restriction: transcriptomic evidence of disrupted developmental and metabolic pathways.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Distal duplication 4q syndrome and distal 10q26 deletion syndrome are rare chromosomal abnormalities associated with complex and overlapping phenotypes. Most cases result from unbalanced inheritance of a parental translocation, yet the specific contributions of each chromosomal segment to the clinical phenotype remain poorly defined. Case presentation: We report on a male preterm infant born at 28 + 6 weeks' gestation who carried a derivative chromosome 10 due to a paternally inherited unbalanced translocation t(4;10)(q31.22;q26.13), leading to a 42.46 Mb duplication of 4q31.22-q35.2 and a 10.77 Mb deletion of 10q26.13-q26.3. The patient presented with severe postnatal linear growth restriction, delayed neurodevelopment, a giant umbilical hernia, bilateral renal hypoplasia, and relative overweight. Thumb anomalies were absent. Methods: Genetic analyses included chromosomal microarray, conventional karyotyping, fluorescence Results: Gene expression analysis confirmed reduced expression of established 10q26-related genes, including Conclusion: This case illustrates how extended terminal deletions of 10q can disrupt key structural and metabolic gene networks. To our knowledge, this is the first transcriptomic characterization of a 10.77 Mb deletion in the 10q26.13-q26.3 region together with a large terminal 4q duplication. Integrating functional transcriptomics with clinical and cytogenetic data may enhance our understanding of rare chromosomal disorders and inform individualized management, including reproductive counseling and longitudinal clinical follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.